Selected article for: "case clinical information and clinical information"
Author: Geng, Jie; Wang, Feng; Huang, Zhiwei; Chen, Xiaobo; Wang, Yuliang
Title: Perspectives on anti-IL-1 inhibitors as potential therapeutic interventions for severe COVID-19
  • Cord-id: oflofh96
  • Document date: 2021_4_17
    • ID: oflofh96
    Snippet: The overproduction of proinflammatory cytokines, resulting in what has been described as a cytokine storm or cytokine release syndrome (CRS), may be the key factor in the pathology of severe coronavirus disease 2019 (COVID-19) and is also a crucial cause of death from COVID-19.With the purpose of finding effective and low-toxicity drugs to mitigate CRS, IL-1 blockade agents, which are one of the safest ways to stop this overwhelming innate immune response, are already available in several prelim
    Document: The overproduction of proinflammatory cytokines, resulting in what has been described as a cytokine storm or cytokine release syndrome (CRS), may be the key factor in the pathology of severe coronavirus disease 2019 (COVID-19) and is also a crucial cause of death from COVID-19.With the purpose of finding effective and low-toxicity drugs to mitigate CRS, IL-1 blockade agents, which are one of the safest ways to stop this overwhelming innate immune response, are already available in several preliminary reports or are under observational trials and may offer an important treatment option in hyperinflammatory COVID-19.In this review, we described the key information in both case reports and clinical studies on the potential beneficial features of IL-1 inhibitors in COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and long term outcome: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute hypoxic respiratory failure and long term outcome: 1
    • acute leukemia and long term outcome: 1, 2
    • acute leukemia and macrophage activation: 1
    • acute respiratory failure and long term outcome: 1, 2, 3, 4, 5
    • acute respiratory failure and macrophage activation: 1, 2, 3, 4, 5
    • acute respiratory syndrome and long term outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory syndrome and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25